Omada Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $260.2 | $169.8 | $122.8 | — |
| Operating income | -$12.0 | -$43.7 | -$66.0 | — |
| Net income | -$12.8 | -$47.1 | -$67.5 | — |
| Cash Flow Statement | ||||
| Free cash flow | $16.9 | -$34.8 | -$50.2 | — |
Shares outstanding 61.2M · Free float 85.5%
Annual filing data through FY ended December 31, 2025; float as of October 1, 2026.
Coverage
October 14, 2026
Theme Survey
GLP-1 companies reshape access and detail treatment dropouts
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground